The flu is skyrocketing in NJ, but is it too late to get the shot? Is it even effective, and will it make me get sick? Here's ...

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

Managing alpha-gal syndrome can be hard for anyone, but for farmers who are in close contact with mammals — the allergy can ...

Teens make a difference in area nursing homes this holiday season. For the third year these area teens come together to sing, ...

Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...

On this "Face the Nation with Margaret Brennan" broadcast, Treasury Secretary Scott Bessent and Rep. Ilhan Omar join Margaret Brennan.

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

A last-minute push from Democrats and four moderate Republicans will force a House vote on renewing enhanced premium tax ...

The FDA has released a plan to stop or reduce the use of primates for testing the safety of certain monoclonal antibodies (mAbs), the latest expansion of the regulator’s efforts to eliminate animal ...

The US Food and Drug Administration (FDA) issued draft guidance outlining specific product types for which the FDA believes six-month non-human primate toxicity testing can be eliminated or reduced.

Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced it will present data on potential treatments for pancreatic and gastric/gastroesophageal junction (G/GEJ) ...